Q3 2024 13F Holders as of 9/30/2024
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
107M
-
Number of holders
-
117
-
Total 13F shares, excl. options
-
68.7M
-
Shares change
-
+47.7K
-
Total reported value, excl. options
-
$267M
-
Value change
-
+$150K
-
Put/Call ratio
-
2
-
Number of buys
-
59
-
Number of sells
-
-36
-
Price
-
$3.89
Significant Holders of MAXCYTE, INC. - Common Stock, par value $0.01 per share (MXCT) as of Q3 2024
125 filings reported holding MXCT - MAXCYTE, INC. - Common Stock, par value $0.01 per share as of Q3 2024.
MAXCYTE, INC. - Common Stock, par value $0.01 per share (MXCT) has 117 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 68.7M shares
of 107M outstanding shares and own 64.32% of the company stock.
Largest 10 shareholders include BlackRock, Inc. (8.49M shares), CADIAN CAPITAL MANAGEMENT, LP (8.19M shares), VANGUARD GROUP INC (5.78M shares), Vitruvian Partners LLP (5.04M shares), MORGAN STANLEY (4.82M shares), MILLENNIUM MANAGEMENT LLC (4.19M shares), Mudita Advisors LLP (3.15M shares), FMR LLC (2.98M shares), GEODE CAPITAL MANAGEMENT, LLC (2.47M shares), and STATE STREET CORP (2.27M shares).
This table shows the top 117 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.